TY - GEN
T1 - Quantitative and long-term cell imaging with computational hyperspectral interferometry
AU - Fu, Rongxin
AU - Su, Ya
AU - Wang, Ruliang
AU - Lin, Xue
AU - Jin, Xiangyu
AU - Yang, Han
AU - Du, Wenli
AU - Shan, Xiaohui
AU - Lv, Wenqi
AU - Huang, Guoliang
N1 - Publisher Copyright:
© 2021 SPIE.
PY - 2021
Y1 - 2021
N2 - Quantitative phase imaging (QPI) has quickly emerged as a powerful tool for label-free living cell morphology and metabolism monitoring. However, for current QPI techniques, interference signals from different layers overlay with each other and impede nanoscale optical sectioning. This phenomenon leads to unsatisfactory performances for optically thick or complex scattering biological samples. To address this challenge, we have developed an alternative quantitative phase microscopy with computational hyperspectral interferometry. Nanoscale optical sectioning could be achieved with Fourier domain spectral decomposition. Morphological fluctuations and refractive index distribution could be reconstructed simultaneously with 89.2 nm axial resolution and 1.91 nm optical path difference sensitivity. With this method, we established a label-free cell imaging system for long-term cellular dry mass measurement and in-situ dynamic single cell monitoring. Different intrinsic cell growth characteristics of dry mass between HeLa cells and Human Cervical Epithelial Cells (HCerEpiC) were studied. The dry mass of HeLa cells consistently increased before M phase, whereas that of HCerEpiC increased and then decreased. The maximum growth rate of HeLa cells was 11.7% higher than that of HCerEpiC. We also use the proposed method and system to explore the relationship between cellular dry mass distributions and drug effects for cancer cells. The results show that cells with higher nuclear dry mass and nuclear density standard deviations were more likely to survive the chemotherapy. The presented work shows potential values for cell growth dynamics research, cell health characterization, medication guidance and adjuvant drug development.
AB - Quantitative phase imaging (QPI) has quickly emerged as a powerful tool for label-free living cell morphology and metabolism monitoring. However, for current QPI techniques, interference signals from different layers overlay with each other and impede nanoscale optical sectioning. This phenomenon leads to unsatisfactory performances for optically thick or complex scattering biological samples. To address this challenge, we have developed an alternative quantitative phase microscopy with computational hyperspectral interferometry. Nanoscale optical sectioning could be achieved with Fourier domain spectral decomposition. Morphological fluctuations and refractive index distribution could be reconstructed simultaneously with 89.2 nm axial resolution and 1.91 nm optical path difference sensitivity. With this method, we established a label-free cell imaging system for long-term cellular dry mass measurement and in-situ dynamic single cell monitoring. Different intrinsic cell growth characteristics of dry mass between HeLa cells and Human Cervical Epithelial Cells (HCerEpiC) were studied. The dry mass of HeLa cells consistently increased before M phase, whereas that of HCerEpiC increased and then decreased. The maximum growth rate of HeLa cells was 11.7% higher than that of HCerEpiC. We also use the proposed method and system to explore the relationship between cellular dry mass distributions and drug effects for cancer cells. The results show that cells with higher nuclear dry mass and nuclear density standard deviations were more likely to survive the chemotherapy. The presented work shows potential values for cell growth dynamics research, cell health characterization, medication guidance and adjuvant drug development.
KW - Cell dynamics research
KW - Cellular dry mass measurement
KW - Computational hyperspectral interferometry
KW - Label-free and long-term cell imaging
KW - Quantitative phase imaging
UR - http://www.scopus.com/inward/record.url?scp=85122388351&partnerID=8YFLogxK
U2 - 10.1117/12.2600858
DO - 10.1117/12.2600858
M3 - Conference contribution
AN - SCOPUS:85122388351
T3 - Proceedings of SPIE - The International Society for Optical Engineering
BT - Optics in Health Care and Biomedical Optics XI
A2 - Luo, Qingming
A2 - Li, Xingde
A2 - Gu, Ying
A2 - Zhu, Dan
PB - SPIE
T2 - Optics in Health Care and Biomedical Optics XI 2021
Y2 - 10 October 2021 through 12 October 2021
ER -